BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
24.92
-0.33 (-1.31%)
May 29, 2026, 4:00 PM EDT - Market closed
BioLife Solutions Revenue
BioLife Solutions had revenue of $27.50M in the quarter ending March 31, 2026, with 24.69% growth. This brings the company's revenue in the last twelve months to $105.75M, up 26.08% year-over-year. In the year 2025, BioLife Solutions had annual revenue of $96.21M with 28.89% growth.
Revenue (ttm)
$105.75M
Revenue Growth
+26.08%
P/S Ratio
11.98
Revenue / Employee
$655,871
Employees
155
Market Cap
1.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 96.21M | 21.57M | 28.89% |
| Dec 31, 2024 | 74.65M | 6.63M | 9.75% |
| Dec 31, 2023 | 68.02M | -8.22M | -10.79% |
| Dec 31, 2022 | 76.24M | -42.92M | -36.02% |
| Dec 31, 2021 | 119.16M | 71.07M | 147.79% |
| Dec 31, 2020 | 48.09M | 20.72M | 75.69% |
| Dec 31, 2019 | 27.37M | 7.63M | 38.64% |
| Dec 31, 2018 | 19.74M | 8.72M | 79.11% |
| Dec 31, 2017 | 11.02M | 2.80M | 33.97% |
| Dec 31, 2016 | 8.23M | 1.78M | 27.57% |
| Dec 31, 2015 | 6.45M | 258.30K | 4.17% |
| Dec 31, 2014 | 6.19M | -2.76M | -30.83% |
| Dec 31, 2013 | 8.95M | 3.29M | 58.03% |
| Dec 31, 2012 | 5.66M | 2.90M | 105.28% |
| Dec 31, 2011 | 2.76M | 677.16K | 32.53% |
| Dec 31, 2010 | 2.08M | 499.97K | 31.61% |
| Dec 31, 2009 | 1.58M | 259.10K | 19.59% |
| Dec 31, 2008 | 1.32M | 350.24K | 36.02% |
| Dec 31, 2007 | 972.26K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| Azenta | 596.48M |
| AtriCure | 552.16M |
| AngioDynamics | 313.73M |
| STAAR Surgical Company | 290.38M |
| LeMaitre Vascular | 256.28M |
| Alamar Biosciences | 87.16M |
| Kestra Medical Technologies | 83.72M |
BLFS News
- 23 days ago - BioLife Solutions reports Q1 EPS 2c, consensus 2c - TheFly
- 23 days ago - BioLife Solutions sees 2026 revenue $112.5M-$115.0M, consensus $112.94M - TheFly
- 23 days ago - BioLife Solutions Earnings Call Transcript: Q1 2026 - Transcripts
- 23 days ago - BioLife Solutions Earnings release: Q1 2026 - Filings
- 23 days ago - BioLife Solutions Quarterly report: Q1 2026 - Filings
- 23 days ago - BioLife Solutions Reports First Quarter 2026 Financial Results - PRNewsWire
- 5 weeks ago - BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 - PRNewsWire
- 5 weeks ago - BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase - PRNewsWire